Clinical Trial Update: Clinical Outcomes of Patients with LAL+ in At Least One Eye

View source ↗

Summary

This clinical trial evaluates outcomes of LAL+ in patients with cataract in at least one eye, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• LAL+

Snippet

Sponsor: Frank A. Bucci, Jr., M.D. | Conditions: IOL, Cataract | Status: ENROLLING_BY_INVITATION